0001610618-23-000034.txt : 20230329
0001610618-23-000034.hdr.sgml : 20230329
20230329173023
ACCESSION NUMBER: 0001610618-23-000034
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230327
FILED AS OF DATE: 20230329
DATE AS OF CHANGE: 20230329
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Stein Jeffrey
CENTRAL INDEX KEY: 0001478831
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36912
FILM NUMBER: 23776324
MAIL ADDRESS:
STREET 1: 6310 NANCY RIDGE DRIVE, SUITE 101
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cidara Therapeutics, Inc.
CENTRAL INDEX KEY: 0001610618
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 461537286
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6310 NANCY RIDGE DRIVE
STREET 2: SUITE 101
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-752-6170
MAIL ADDRESS:
STREET 1: 6310 NANCY RIDGE DRIVE
STREET 2: SUITE 101
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: K2 THERAPEUTICS, INC.
DATE OF NAME CHANGE: 20140611
4
1
wf-form4_168012541068205.xml
FORM 4
X0407
4
2023-03-27
0
0001610618
Cidara Therapeutics, Inc.
CDTX
0001478831
Stein Jeffrey
6310 NANCY RIDGE DRIVE, STE 101
SAN DIEGO
CA
92121
1
1
0
0
President & CEO
0
Common Stock
2023-03-27
4
A
0
271750
0
A
1202385
D
Common Stock
281602
I
By trust
Common Stock
42009
I
By son
Employee Stock Option (right to buy)
1.01
2023-03-27
4
A
0
543500
0
A
2033-03-26
Common Stock
543500.0
543500
D
Represents time-based Restricted Stock Units (RSUs) granted on March 27, 2023. All RSUs vest in three equal annual installments, with 1/3 vesting on each of March 10, 2024, 2025, and 2026, subject to continuous service through each such vesting date.
Includes 8,000 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan (ESPP) on May 20, 2022 and November 18, 2022.
The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of March 27, 2023.
/s/ Shane Ward, Attorney-in-Fact
2023-03-29